Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model.

Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model. Abstract Text:

    jodie e moreauJodie E Moreau,kristen andersonKristen Anderson,joshua r mauneyJoshua R Mauney,trang nguyenTrang Nguyen,david l kaplanDavid L Kaplan,michael rosenblattMichael Rosenblatt,

    The high frequency and mortality associated with breast cancer metastasis to bone has motivated efforts to elucidate tumor-stroma interactions in the bone microenvironment contributing to invasion and proliferation of metastatic cells. The development of engineered tissues has prompted the integration of engineered bone scaffolds into animal models as potential targets for metastatic spread. Silk scaffolds were coupled with bone morphogenetic protein-2 (BMP-2), seeded with bone marrow stromal cells (BMSC), and maintained in culture for 7 weeks, 4 weeks, and 1 day before s.c. implant in a mouse model of human breast cancer metastasis from the orthotopic site. Following injection of SUM1315 cells into mouse mammary fat pads, tumor burden of implanted tissues was observed only in 1-day scaffolds. Scaffold development and implantation was then reinitiated to identify the elements of the engineered bone that contribute to metastatic spread. Untreated scaffolds were compared with BMP-2-coupled, BMSC-seeded, or BMP-2/BMSC-combined treatment. Migration of SUM1315 cells was detected in four of four mice bearing scaffolds with BMP-2 treatment and with BMSC treatment, respectively, whereas only one of six mice of the BMP-2/BMSC combination showed evidence of metastatic spread. Histology confirmed active matrix modeling and stromal cell/fibroblast infiltration in scaffolds positive for the presence of metastasis. These results show the first successful integration of engineered tissues in a model system of human breast cancer metastasis. This novel platform now can be used in continued investigation of the bone environment and stem cell contributions to the process of breast cancer metastasis.

    Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model. Publishing Authors By Initials

    je moreauJE Moreau,k andersonK Anderson,jr mauneyJR Mauney,t nguyenT Nguyen,dl kaplanDL Kaplan,m rosenblattM Rosenblatt,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Cancer research

    VOLUME: 67

    Page Numbers: 10304-8

    Journal Abbreviation: Cancer Res.

    ISSN: 1538-7445

    DAY: 1

    MONTH: Nov

    YEAR: 2007

    Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 2984705

    Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model.

    AFFILIATION: Department of Physiology, Tufts University School of Medicine, Boston, MA 02111, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Cancer Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News